Beasley Allen has one of the largest and most technologically advanced Mass Torts practices in the country. The Mass Torts division represents numerous people in claims against companies that manufacture and/or market defective pharmaceuticals and/or medical devices. The resources devoted to this division allow the firm to competently and conscientiously handle any group of cases, no matter how large, along with particular catastrophic injury cases.
Our firm was recently involved in one of the greatest victories in Mass Torts history, against drug manufacturer Merck regarding the drug Vioxx. After more than five years of hard-fought and difficult litigation, Merck agreed to pay $4.85 billion, the largest pharmaceutical settlement in U.S. history, to resolve certain Vioxx-related claims involving plaintiffs who suffered a heart attack, including sudden cardiac death, or a stroke.
The South Carolina Supreme Court has ordered Johnson & Johnson subsidiary Janssen Pharmacetuicals to pay $136 million to the state for deceptively marketing its antipsychotic drug Risperdal. The decision upholds penalties against the company but reduces the damages, which were originally set at $327 million by a trial court in 2011. Justices said the penalty had to be reduced because of South Carolina’s three-year statute of limitations. Risperdal, known generically as risperidone, is used to treat adults and children with schizophrenia, bipolar disorder and irritability with autism. The drug has also been prescribed off label to treat attention deficit hyperactivity ... Read More
Statin medications, such as the widely prescribed Lipitor, can drive down elevated cholesterol levels, but they have failed to substantially improve users’ chances of having a heart attack or stroke. The drugs also have numerous serious side effects that are pushed under the radar by supporters of statin therapy, according to a study published in the March edition of the medical journal Expert Review of Clinical Pharmacology. Dr. David M. Diamond, a professor of psychology, molecular pharmacology and physiology at the University of South Florida, and Dr. Uffe Ravnskov, an independent health researcher and an expert in cholesterol and cardiovascular ... Read More
An 18-year-old boy who became infected with a deadly superbug after undergoing a procedure using a specialized endoscope at UCLA’s Ronald Reagan Medical Center has filed a lawsuit against the manufacturer of the surgical tool. The patient, high school student Aaron Young, remains hospitalized with carbapenem-resistant enterobacteriaceae, or CRE, a highly antibiotic-resistant bacteria that kills up to 50 percent of infected patients. The lawsuit names Olympus Corp. of Americans, manufacturers of the specialized endoscope, known as a duodenoscope. UCLA and the University of California regents may also be added as defendants following more investigations into the matter. Duodenoscopes are flexible fiber-optic ... Read More
The Food and Drug Administration (FDA) has approved the first seamless diabetes glucose monitoring app, which can wirelessly transmit glucose readings directly to an iPhone, giving diabetics more flexibility when it comes to managing their disease. Federal drug and medical device regulators gave a nod to the new version of the Dexcom Share platform, which works with the Dexcom G4 continuous glucose monitor (CGM). The original Dexcom Share, which was approved by the FDA in October 2014, was a docking cradle peripheral that could transmit Dexcom’s glucose readings to a nearby iPhone. The readings were then uploaded through the cloud ... Read More
The effect of anesthesia on infants and children has been hotly debated for years, with some animal studies suggesting the drugs can harm developing brains. But there is no clear evidence that the drugs can cause harm, such as developmental delays or behavior problems later in life. Doctors don’t want to add concern to parents whose children need general anesthesia for crucial surgery. A group of researchers has partnered with the Food and Drug Administration (FDA) to settle the matter once and for all. “Millions of kids safely undergo anesthesia,” said SmartTots co-author Dr. Beverly Orser, a professor of anesthesia ... Read More
Two recalls have been issued for Teleflex Medical’s MAQUET Servo Humidifier 163 for connector cracks and cracks in connector tubes that may result in serious health consequences including death to patients. Some connector cracks were found when preparing patients for support with a ventilator. These cracks could cause oxygen and other gasses to leak from the ventilator and not deliver sufficient treatment to patients. Cracks were also found in the connector tubes during the manufacturing process and some devices were distributed before the problem was identified. The MAQUET Servo Humidifier is a heat and moisture condenser that is placed over ... Read More
The Food and Drug Administration (FDA) is warning health care professionals that some MRI units may have been modified to disable the Magnet Rundown Unit (MRU), which is one method to shut off the magnet field of the MRI in case of emergency, such as when a metal (ferrous) object is brought into the magnet field. In the event of an emergency, a delay in shut off can result in life-threatening injuries. At least two hospital employees have been injured when they entered the MRI room carrying a metal container. The recall is being issued because this defect may cause ... Read More
The Food and Drug Administration (FDA) has ordered the recall of 10 lots of the antibiotic colistimethate and three lots of antibacterial drug Rifampin manufactured by Emcure Pharmaceuticals and distributed by Heritage because of manufacturing practices that put the injectable drugs’ sterility in question. Intravenous administration of non-sterile injection products may result in a site-specific or systemic infection, which may lead to hospitalization, significant morbidity (such as organ damage), or death. To date, Heritage has not received any reports of adverse events in patients resulting from use of the injections affected by the recall. Affected products include 10 lots of colistimethate ... Read More
C.R. Bard and a woman who claims she was injured by the medical device maker’s defective transvaginal mesh are on the verge of a settlement, just days before the lawsuit was scheduled to go to trial. Debra Wise’s lawsuit was part of a federal multidistrict litigation in West Virginia. The “pending settlement” was signed off on by U.S. District Judge Joseph Goodwin, and the case was ordered off the active docket in the litigation. Wise’s lawsuit was originally filed in West Virginia state court in the Circuit Court of Cabell County before it was transferred to the federal multidistrict litigation. ... Read More
A congressman whose district includes the UCLA hospital where more than 100 patients were exposed to a drug-resistant superbug is calling for the House Committee on Oversight and Government Reform to hold the Food and Drug Administration (FDA) accountable for not taking action sooner when it learned that certain medical devices could spread the dangerous bacteria from patient to patient. Rep. Ted Lieu, D-Calif., who also serves on the House Committee on Oversight and Government Reform, urged his fellow committee members to hold a hearing on the matter, adding that the agency’s recent safety alert failed to adequately provide health care ... Read More